ADMA Biologics Inc (ADMA) Company Report Dec. 07, 2022, 00:04 UTC 42 ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate Comment Full text
Lexaria Bioscience Corp. (LEXX) Company Report Dec. 06, 2022, 22:40 UTC 43 New SEC Form for Lexaria Bioscience Corp. Comment Full text
Journey Medical Corporation (DERM) Company Report Dec. 06, 2022, 00:10 UTC 45 Journey Medical Corporation to Participate in Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech/Diagnostic Conference Comment Full text
Veru Inc. (VERU) Company Report Dec. 05, 2022, 23:30 UTC 40 New SEC Form for Veru Inc. Comment Full text
Cytokinetics Inc (CYTK) Company Report Dec. 03, 2022, 00:05 UTC 44 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Dec. 02, 2022, 01:05 UTC 41 Rigel Announces U.S. FDA Approval of REZLIDHIA™(olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation Comment Full text
Cytokinetics Inc (CYTK) Company Report Dec. 02, 2022, 00:05 UTC 41 Cytokinetics Announces Presentation at the Virtual 33rd International Symposium on ALS/MND Comment Full text
Luna Innovations Incorporated (LUNA) Company Report Dec. 01, 2022, 16:50 UTC 39 Luna to Present at Singular Research’s Best of the Uncovered Investor Conference on December 8, 2022 Comment Full text
Arrowhead Pharmaceuticals Inc (ARWR) Company Report Nov. 29, 2022, 00:20 UTC 42 New Form 10-K for Arrowhead Pharmaceuticals, Inc. Comment Full text